Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

8.85
Delayed Data
As of Feb 24
 +0.20 / +2.31%
Today’s Change
3.52
Today|||52-Week Range
10.00
+21.90%
Year-to-Date
No recent news for Corcept Therapeutics Inc.

Today’s Trading

Previous close8.65
Today’s open8.57
Day’s range8.50 - 8.87
Volume434,606
Average volume (3 months)712,640
Market cap$982.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+80.65%
Earnings growth (this year)+166.67%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+89.39%
P/E ratio221.3
Price/Sales10.59
Price/Book52.46

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.06+0.31%
SGYPSynergy Pharmaceutic...+0.01+0.18%
DEPODepomed Inc-0.51-3.03%
IPXLImpax Laboratories I...-0.35-2.43%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$50.3M
Annual profit (last year)-$6.4M
Net profit margin-12.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs